These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 573340)

  • 21. Intraventricular muscle band mimicking asymmetric ventricular septal hypertrophy and hypertrophic cardiomyopathy.
    Maron BJ; Klues HG; McIntosh C
    Am J Cardiol; 1992 Jul; 70(1):130-1. PubMed ID: 1615861
    [No Abstract]   [Full Text] [Related]  

  • 22. [Electrocardiographic signs of hypertrophy of the interventricular septum in patients with hypertrophic cardiomyopathy].
    Ianovskiĭ GV; Stadniuk LA; Kovtun LI
    Vrach Delo; 1990 Mar; (3):60-2. PubMed ID: 2368365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical ASH)].
    Koga Y; Takahashi H; Ifuku M; Itaya M; Adachi K; Toshima H
    J Cardiogr; 1984 Aug; 14(2):301-10. PubMed ID: 6543446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
    Park KM; Im SI; Kim EK; Lee SC; Park SJ; Kim JS; On YK
    PLoS One; 2016; 11(6):e0156410. PubMed ID: 27258035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcoronary ablation of septal hypertrophy (Tash).
    Sathyamurthy I
    Indian Heart J; 2006; 58(4):371-4. PubMed ID: 19039161
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathophysiology of asymmetric septal hypertrophy.
    Maron BJ; Henry WL; Epstein SE
    Ann Radiol (Paris); 1977; 20(3-4):359-66. PubMed ID: 141901
    [No Abstract]   [Full Text] [Related]  

  • 27. Distribution of hypertrophy in obstructive and non-obstructive types of hypertrophic cardiomyopathy.
    Gregor P; Widimský P; Cervenka V; Sládková T; Vísek V
    Cor Vasa; 1984; 26(4):275-80. PubMed ID: 6541554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear magnetic resonance in hypertrophic cardiomyopathy.
    Been M; Kean D; Smith MA; Douglas RH; Best JJ; Muir AL
    Br Heart J; 1985 Jul; 54(1):48-52. PubMed ID: 3160375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinico-pathomorphologic evaluation of changes of the interventricular heart septum in hypertrophic cardiomyopathy].
    Rozenberg VD
    Kardiologiia; 1990 Feb; 30(2):66-9. PubMed ID: 2348623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biventriculographic and clinicopathologic evaluation of apical hypertrophy: with reference to asymmetrical septal hypertrophy with hypertension].
    Genda A; Taga K; Nakayama A; Nunoda S; Horita Y; Sugihara N; Takeda R
    J Cardiogr; 1985 Jun; 15(2):327-38. PubMed ID: 4093618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypertrophic cardiomyopathy with obstruction].
    Schmidt E; Most E; Bender F; Gradaus D
    Med Klin; 1979 Feb; 74(6):173-81. PubMed ID: 368549
    [No Abstract]   [Full Text] [Related]  

  • 32. Specificity of light and electron microscopic features of hypertrophic obstructive and nonobstructive cardiomyopathy. Qualitative, quantitative and etiologic aspects.
    Ferrans VJ; Rodríguez ER
    Eur Heart J; 1983 Nov; 4 Suppl F():9-22. PubMed ID: 6686548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
    Ohtsuki K; Sugihara H; Ito K; Matsumoto K; Taniguchi Y; Terada K; Nakagawa T; Shima T; Kuribayashi T; Ochiai M
    Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR imaging of hypertrophic cardiomyopathy.
    Park JH; Kim YM; Chung JW; Park YB; Han JK; Han MC
    Radiology; 1992 Nov; 185(2):441-6. PubMed ID: 1410351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Images in cardiovascular medicine. Rapid progression of extreme septal hypertrophic cardiomyopathy.
    Jefferies JL; Moreira W; Massumi A; Stainback RF
    Circulation; 2003 Nov; 108(19):e136. PubMed ID: 14609999
    [No Abstract]   [Full Text] [Related]  

  • 36. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
    Bahl A
    Indian Heart J; 2008; 60(3):273. PubMed ID: 19240323
    [No Abstract]   [Full Text] [Related]  

  • 37. Images in cardiovascular medicine. Cardiac rhabdomyoma in an adult with a previous presumptive diagnosis of septal hypertrophy.
    Wage R; Kafka H; Prasad S
    Circulation; 2008 Jun; 117(22):e469-70. PubMed ID: 18519852
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Lieder F; Bartelsmeier M; Leuner C; Borchert B; Meyer zu Vilsendorf D; Strunk-Mueller C; Reinhardt J; Feuchtl A; Stellbrink C; Kuhn H
    J Am Coll Cardiol; 2007 Jun; 49(24):2356-63. PubMed ID: 17572252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymmetric septal hypertrophy in a 41-year-old woman with Noonan's syndrome.
    Doyama K; Hirose K; Fujiwara H
    Chest; 1990 Jun; 97(6):1480-1. PubMed ID: 2347236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change of the degree of septal hypertrophy in hypertrophic obstructive cardiomyopathy under procainamide treatment. A case report.
    Schwartz J; Rafael C; Rozenfeld V; Abu-Much Z; Schoham H
    Angiology; 1995 Jan; 46(1):83-5. PubMed ID: 7818161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.